申请人:The Procter & Gamble Company
公开号:US20030083351A1
公开(公告)日:2003-05-01
Compounds having a structure according to Formula (I):
1
are effective in a method of increasing erythropoietin and vascularization of tissue in a subject in need thereof.
具有以下结构的化合物(I)1根据一种增加受需要者的红细胞生成素和组织血管化的方法是有效的。